4.7 Article

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)

Related references

Note: Only part of the references are listed.
Article Oncology

Biomarkers for monitoring antiangiogenic therapy

Rupal S. Bhatt et al.

CLINICAL CANCER RESEARCH (2007)

Review Multidisciplinary Sciences

Angiogenesis as a therapeutic target

N Ferrara et al.

NATURE (2005)

Review Multidisciplinary Sciences

Angiogenesis in life, disease and medicine

P Carmeliet

NATURE (2005)

Article Biochemistry & Molecular Biology

Extracellular superoxide dismutase

E Nozik-Grayck et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)

Review Neurosciences

Ceruloplasmin in neurodegenerative diseases

V Vassiliev et al.

BRAIN RESEARCH REVIEWS (2005)

Article Biochemistry & Molecular Biology

Serum superoxide dismutase 3 (extracellular superoxide dismutase) activity is a sensitive indicator of Cu status in rats

WT Johnson et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2005)

Review Oncology

Control of copper status for cancer therapy

VL Goodman et al.

CURRENT CANCER DRUG TARGETS (2005)

Review Pharmacology & Pharmacy

Antiangiogenic therapy in cancer

F Doñate

DRUGS OF THE FUTURE (2005)

Article Biochemistry & Molecular Biology

Copper transport and metabolism are normal in aceruloplasminemic mice

LA Meyer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)